Target intelligence / Profile preview

Histone H1.1 (H1.1)

Target
H1.1
Molecular classification
Histone, Chromatin structural protein, Linker histone
01

Overview

Histone H1.1 is a member of the H1 linker histone family, a group of non-core histone proteins in eukaryotic chromatin that bind to the DNA between nucleosomes, known as linker DNA, and play a crucial role in stabilizing higher-order chromatin structures[1][3]. Unlike core histones (H2A, H2B, H3, H4), H1 is not part of the nucleosome bead but binds at the entry and exit points of DNA on the nucleosome, promoting chromatin fiber compaction and organization[1][3]. The H1 family comprises several subtypes—including H1.1—characterized by a central globular domain and highly variable terminal tails[1][3]. H1.1 contributes to the regulation of gene expression, chromatin dynamics, and modulation of DNA accessibility by controlling the folding of chromatin and acting as both a positive and negative regulator of transcription, depending on context[1][3]. Its biological roles are further influenced by posttranslational modifications such as phosphorylation, methylation, and acetylation, which regulate its activity during processes like the cell cycle and embryogenesis[3]. While essential for chromatin architecture, there are no current drugs that target H1.1 directly, and it is not considered a canonical therapeutic target or druggable receptor[3]. Deficiency or overexpression of H1.1 can lead to structural and functional chromatin abnormalities, highlighting its fundamental but non-specialized cellular role[1][3].

Other names
H1-1H1F1HIST1H1AH1.1H1aHistone H1aH1AHIST1histone H1.1H1 histone family, member 1histone 1, H1ahistone H1ahistone cluster 1 H1 family member ahistone cluster 1, H1a
02

Biological functions

Chromatin compaction/condensationRegulation of gene transcriptionHigher-order chromatin structure organizationRegulation of DNA accessibilityCell cycle-dependent chromatin changes
03

Disease associations

Other (no strong direct association to major disease classes; possible indirect links to cancer and developmental disorders through roles in chromatin regulation)
04

Safety considerations

Genetic redundancy with other H1 variantsimpacts on global chromatin structure and gene regulation if targetedlack of specificity for therapeutic modulation

Beyond the preview

Go deeper on Histone H1.1 (H1.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H1.1 (H1.1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call